1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,005 | 1,065 | 10:20 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| MODULIGHT Aktie jetzt für 0€ handeln | |||||
| 21.08. | Modulight Q2 2026 slides: margins surge 185% as revenue falls 18% | 2 | Investing.com | ||
| 21.08. | Earnings Call: Modulight steigert Margen im zweiten Quartal trotz Umsatzrückgang | - | Investing.com Deutsch | ||
| 21.08. | Earnings Call Transkript: Modulight meldet für Q2 2026 höhere Margen bei sinkendem Umsatz | - | Investing.com Deutsch | ||
| 21.08. | Modulight Oyj Q2 Sales Decline | 1 | RTTNews | ||
| 04.05. | Modulight Oyj: Resolutions of Modulight Corporation's Annual General Meeting and Inaugural Meeting of the Board of Directors on 4 May 2026 | 238 | GlobeNewswire (Europe) | Modulight Corporation | Company Release | May 04, 2026 at 15:55:00 EEST
The Annual General Meeting of Modulight Corporation was held on 4 May 2026 at 1 p.m. (Finnish time) at Kampusareena Auditorium... ► Artikel lesen | |
| 24.04. | Modulight Oyj: Profitability improved despite the decline in revenue | 461 | GlobeNewswire (Europe) | Modulight Corporation | Company Release | April 24, 2026 at 10:30:00 EEST
This release is a summary of Modulight's interim report for January-March 2026. The whole report is attached to this stock exchange... ► Artikel lesen | |
| 21.04. | Modulight Oyj: Inside information: Modulight introduces financial guidance for 2026 | 211 | GlobeNewswire (Europe) | Modulight Corporation | Inside Information | April 21, 2026 at 15:21:00 EEST
Modulight Corporation announces that, as of today, the company will provide financial guidance on its revenue and EBITDA.... ► Artikel lesen | |
| 20.02. | Modulight Oyj: Record Year in Revenue Growth | 563 | GlobeNewswire (Europe) | Modulight Corporation | Company Release | February 20, 2026 at 11:00:00 EET
This release is a summary of Modulight's financial statements bulletin 2025. The whole report is attached to this stock exchange... ► Artikel lesen | |
| 24.10.25 | Modulight Oyj: Continued Improvement in Revenue and Profitability | 331 | GlobeNewswire (Europe) | Modulight Corporation | Company Release | October 24, 2025 at 13:00:00 EEST
This release is a summary of Modulight's interim report for January-September 2025. The whole report is attached to this stock... ► Artikel lesen |
9 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| THERMO FISHER | 534,40 | +0,53 % | Wachstumsausblick überzeugt: UBS stuft Thermo Fisher Scientific auf "Kaufen" hoch | ||
| NYXOAH | 1,370 | 0,00 % | Nyxoah (NYXH) Begins BREATHE Study. Can Real-World Evidence Drive Genio Adoption? | ||
| OPTOMED | 1,558 | -0,64 % | Optomed Oyj: Half-year report January - June 2026 | Optomed Plc Stock Exchange Release 14 August 2026 at 9.00, Helsinki
Optomed Plc: Half-year report January - June 2026
April - June 2026
Revenue decreased by 8.6 percent to EUR 3.5 (3.8) million.
Currency-adjusted... ► Artikel lesen | |
| NEXSTIM | 9,550 | -0,52 % | Original-Research: Nexstim (von NuWays AG): BUY | Original-Research: Nexstim - from NuWays AG
02.09.2026 / 09:00 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content... ► Artikel lesen | |
| HEARTFLOW | 49,540 | 0,00 % | Heartflow, Inc.: Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half | FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty, supporting... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 60,27 | -0,05 % | BrightSpring Health Services auf Jefferies-Konferenz: Wachstum auf breiter Front | ||
| ALIGNMENT HEALTHCARE | 12,935 | 0,00 % | Alignment Healthcare USA, LLC: Alignment Health's Fifth Annual Survey Finds Seniors Falling Further Behind: Aging in Place Challenges Continue to Rise as Support Gaps Widen | ||
| BASEL MEDICAL GROUP | 7,180 | +0,56 % | Morning Market Movers: Aehr Test Systems, Pentair, NextCure, Basel Medical Group See Big Swings | BEIJING (dpa-AFX) - At 8:30 a.m. ET on Wednesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 14,395 | +0,10 % | Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 13,390 | 0,00 % | LifeStance Health Group, Inc. - 8-K, Current Report | ||
| PROCEPT BIOROBOTICS | 21,025 | 0,00 % | Oppenheimer reiterates Procept BioRobotics stock rating | ||
| STARLING ONCOLOGY INSTITUTE | 6,520 | 0,00 % | The Oncology Institute Rebrands as Starling Oncology | CERRITOS, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI" or "the Company"), one of the largest value-based oncology groups in the United States, announced today that... ► Artikel lesen | |
| GENEDX | 89,77 | +0,03 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| BETA BIONICS | 16,710 | -0,12 % | Beta Bionics, Inc.: Beta Bionics Announces FDA Clearance of Mint, the Company's Transformative Patch Pump, and Unveils 3D Intelligence as its Next-Generation Insulin Dosing Algorithm | Mint features a new and innovative patch pump architecture Full Mint U.S. commercialization expected to begin in Q1 2027 Manufacturing capacity expected to produce at least 1.5 million disposable... ► Artikel lesen | |
| FRESENIUS | 45,515 | -0,42 % | UBS stuft Fresenius SE auf 'Buy' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Fresenius mit einem Kursziel von 56 Euro auf "Buy" belassen. Analyst Graham Doyle hält die Sorgen um das US-Geschäft mit... ► Artikel lesen |
MODULIGHT OYJ gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 1,005 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MODULIGHT OYJ finden Sie auf Wallstreet Online.